Managing Heart Disease and Heart Failure in Your Feline Patients (Sponsored by IDEXX)
This online on-demand archived Webinar will highlight the importance of differentiating between heart disease and heart failure and will discuss the impact on diagnosis, therapy and monitoring your feline patients. (1 CE credit)
This online on-demand archived Webinar will highlight the importance of differentiating between heart disease and heart failure and will discuss the impact on diagnosis, therapy and monitoring your feline patients. (1 CE credit)
For more information and to register, click here.
Oral solution approved by the FDA for canine heart failure
November 22nd 2024Vetmedin Solution from Boehringer Ingelheim is indicated for treatment of cases caused by myxomatous mitral valve disease or dilated cardiomyopathy and is the first oral solution approved by the FDA for this use in dogs
Read More
Podcast CE: Canine cardiology: the practical guide to the mitral valve patient
July 19th 2023Learn about the prevalence of myxomatous mitral valve disease, guidelines for staging heart disease, proactive diagnostic workup, the importance of spironolactone and aldosterone blocking, and the benefits of combination therapy for improved outcomes in canine patients
Listen
